(Markets Insider) Aug 7, 2018 - Array BioPharma Inc. today announced it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for encorafenib (BRAFTOVI™), in combination with binimetinib (MEKTOVI®) and cetuximab for the treatment of patients with BRAFV600E-mutant metastatic colorectal cancer...
(FACS) July 23, 2018 - Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.
However, a new large-scale retrospective study is the first to demonstrate a potential improvement of these outcomes.
Study results show that nearly...
There are no Colorectal OBR Green articles.